Current:Home > NewsAddiction drug maker will pay more than $102 million fine for stifling competition-DB Wealth Institute B2 Expert Reviews
Addiction drug maker will pay more than $102 million fine for stifling competition
View Date:2024-12-24 09:51:38
The maker of an important addiction treatment medication has agreed to pay $102 million dollars to settle claims it stifled competition. Indivior makes Suboxone, which reduces drug cravings in people with opioid use disorder.
The Virginia-based Indivior introduced Suboxone in 2002 and then, according to state attorneys general, used "monopolistic" strategies to keep generic versions of the opioid-treatment medication off the market.
New York Attorney General Letitia James released a statement saying Indivior "selfishly maneuvered to keep less expensive versions of a life-saving drug out of the hands of millions of Americans" as the opioid crisis grew.
States sued the company in 2016. This settlement with 41 states and the District of Columbia ends that legal fight.
In a statement, Indivior admitted no wrongdoing and said this deal allows the company to focus on patient care.
"We take our role as a responsible steward of medications for addiction and rescue extremely seriously," said Indivior CEO Mark Crossley. "Resolving these legacy matters at the right value allows us to further this mission for patients."
Company officials said they expect to pay the $102.5 million from cash on hand later this month.
veryGood! (2)
Related
- Rafael dissolves into a low pressure system in the Gulf of Mexico after hitting Cuba as a hurricane
- 36 jours en mer : récit des naufragés qui ont survécu aux hallucinations, à la soif et au désespoir
- Some experts push for transparency, open sourcing in AI development
- How Texas mom Maria Muñoz became an important witness in her own death investigation
- Rep. Michael McCaul of Texas says he was detained in airport over being ‘disoriented’
- Klarna CEO Siemiatkowski says buy now, pay later is used by shoppers who otherwise avoid credit
- Nobody went to see the Panthers-Falcons game despite ridiculously cheap tickets
- 3 bystanders were injured as police fatally shot a man who pointed his gun at a Texas bar
- Kentucky woman seeking abortion files lawsuit over state bans
- Bad coaches can do a lot of damage to your child. Here's 3 steps to deal with the problem
Ranking
- Tech consultant testifies that ‘bad joke’ led to deadly clash with Cash App founder Bob Lee
- Quaker Oats recalls some of its granola bars, cereals for possible salmonella risk
- Gary Sheffield deserves to be in baseball's Hall of Fame: 'He was a bad boy'
- New details emerge about Alex Batty, U.K. teen found in France after vanishing 6 years ago: I want to come home
- Cowboys owner Jerry Jones responds to CeeDee Lamb's excuse about curtains at AT&T Stadium
- Jets eliminated from playoffs for 13th straight year, dealing blow to Aaron Rodgers return
- Serbia’s populist leader relies on his tested playbook to mastermind another election victory
- Jeff Roe, main strategist for DeSantis super PAC, resigns
Recommendation
-
What to know about Mississippi Valley State football player Ryan Quinney, who died Friday
-
Mostert, Tagovailoa lead Dolphins to a 30-0 victory over the Jets without Tyreek Hill
-
Fantasy football winners, losers from Week 15: WRs Terry McLaurin, Josh Palmer bounce back
-
Ukraine’s military chief says one of his offices was bugged and other devices were detected
-
Don't Miss Cameron Diaz's Return to the Big Screen Alongside Jamie Foxx in Back in Action Trailer
-
US Indo-Pacific commander is ‘very concerned’ about escalation of China-Russia military ties
-
Your autograph, Mr. Caro? Ahead of 50th anniversary, ‘Power Broker’ author feels like a movie star
-
October 2023 in photos: USA TODAY's most memorable images